Medicine embraces nano: diagnostics to delivery
Surinder P Singh,1 Rishi Shanker,2 Srinivas Sridhar,3 Thomas J Webster3
1CSIR-National Physical Laboratory, New Delhi, India; 2School of Arts & Sciences, Ahmedabad University, Ahmedabad, India; 3College of Engineering, Northeastern University, Boston, USA
In the 21st century, nanomedicine is one of the fastest growing research areas in medicine and is expected to revolutionize health care by developing innovative diagnostic and therapeutic tools. In this context, an International Conference on Translational Nanomedicine (T-NANO 2014) was jointly organized by the CSIR-National Physical Laboratory, New Delhi, India; Northeastern University, Boston, USA; and the Institute of Life Sciences (ILS), Ahmedabad University, Ahmedabad, India, under the auspices of the IUSSTF-funded Indo-US Joint Centre on Nanomedicine for Head and Neck Cancer, Ahmedabad, from December 15–17, 2014. Center partners included Northeastern University; DFCI, Harvard Medical School, USA; CSIR-National Physical Laboratory; the CSIR-Indian Institute of Toxicology Research, Lucknow, India; the All India Institute of Medical Sciences, New Delhi, India; and the ILS. The central theme of the conference was to discuss the recent developments in nanotherapeutics, theranostics, nanomedicines, regenerative medicine, tissue engineering, diagnostics and imaging, toxicology, models for disease biology, and commercialization of all nanomedicines. The topics covered provided an understanding of how nanomaterials and nanotechnologies have played a pivotal role in advancing our understanding of biomedicine and in generating new tools toward the goal of improving human health.
The authors report no conflicts of interest in this work.
Dove Medical Press encourages responsible, free and frank academic debate. The content of the International Journal of Nanomedicine ‘Editorial’ section does not necessarily represent the views of Dove Medical Press, its officers, agents, employees, related entities or the International Journal of Nanomedicine editors. While all reasonable steps have been taken to confirm the content of each Editorial, Dove Medical Press accepts no liability in respect of the content of any Editorial, nor is it responsible for the content and accuracy of any Editorial.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]